Viewing Study NCT02250495


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2025-12-30 @ 11:02 PM
Study NCT ID: NCT02250495
Status: TERMINATED
Last Update Posted: 2015-09-14
First Post: 2014-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Sympara VIBE Study for Hypertension
Sponsor: Sympara Medical, Inc.
Organization:

Study Overview

Official Title: VIBE: A Clinical Study to Evaluate the Sympara Therapeutic System for the Treatment of Hypertension
Status: TERMINATED
Status Verified Date: 2015-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Company closed
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VIBE
Brief Summary: The purpose of the VIBE study is to evaluate the efficacy and safety of the Sympara Therapeutic System in the treatment of hypertension
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: